Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
The Oncologist
|
June 22, 2021
Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform
Edwin Lin, Andrew W Hahn, Roberto H Nussenzveig, et al.
Kidney Cancer (Clifton, Va.)
|
September 12, 2024
Effectiveness of Second-Line Cabozantinib in Metastatic Clear Cell Renal Cell Carcinoma Patients After First-Line Treatment with Immune Checkpoint Inhibitor-based Combinations
Arshit Narang, Georges Gebrael, Yeonjung Jo, et al.
Urology Practice
|
October 30, 2023
Impact of Initial Timing of Metastatic Disease on Survival in Patients With Newly Diagnosed Metastatic Castration-Resistant Prostate Cancer Treated With Androgen Receptor Pathway Inhibitors
Georges Gebrael, Nicolas Sayegh, Nishita Tripathi, et al.
Urology Practice
|
October 31, 2023
Reply by Authors
Georges Gebrael, Nicolas Sayegh, Nishita Tripathi, et al.
JAMA Network Open
|
July 9, 2024
Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial
Georges Gebrael, Yeonjung Jo, Umang Swami, et al.
JAMA Network Open
|
March 20, 2025
Treatment and Attrition Trends for Metastatic Clear Cell Renal Cell Carcinoma in the US
Zeynep Irem Ozay, Yeonjung Jo, Gliceida Galarza Fortuna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer
Nicolas Sayegh, Ryon P Graf, Umang Swami, et al.
Cancer
|
April 2, 2024
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor
Georges Gebrael, Yeonjung Jo, Vinay Mathew Thomas, et al.
European Urology Focus
|
April 5, 2024
Impact of Synchronous versus Metachronous Metastasis on Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with First-line Immune Checkpoint Inhibitor-based Combinations
Georges Gebrael, Luis Meza, Xiaochen Li, et al.
JAMA Network Open
|
April 7, 2026
Trends and Disparities in the Use of Next-Generation Sequencing in Patients With Cancer in the United States
Chadi Hage Chehade, Zeynep Irem Ozay, Yeonjung Jo, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
The Oncologist
|
June 22, 2021
Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform
Edwin Lin, Andrew W Hahn, Roberto H Nussenzveig, et al.
Kidney Cancer (Clifton, Va.)
|
September 12, 2024
Effectiveness of Second-Line Cabozantinib in Metastatic Clear Cell Renal Cell Carcinoma Patients After First-Line Treatment with Immune Checkpoint Inhibitor-based Combinations
Arshit Narang, Georges Gebrael, Yeonjung Jo, et al.
Urology Practice
|
October 30, 2023
Impact of Initial Timing of Metastatic Disease on Survival in Patients With Newly Diagnosed Metastatic Castration-Resistant Prostate Cancer Treated With Androgen Receptor Pathway Inhibitors
Georges Gebrael, Nicolas Sayegh, Nishita Tripathi, et al.
Urology Practice
|
October 31, 2023
Reply by Authors
Georges Gebrael, Nicolas Sayegh, Nishita Tripathi, et al.
JAMA Network Open
|
July 9, 2024
Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial
Georges Gebrael, Yeonjung Jo, Umang Swami, et al.
JAMA Network Open
|
March 20, 2025
Treatment and Attrition Trends for Metastatic Clear Cell Renal Cell Carcinoma in the US
Zeynep Irem Ozay, Yeonjung Jo, Gliceida Galarza Fortuna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer
Nicolas Sayegh, Ryon P Graf, Umang Swami, et al.
Cancer
|
April 2, 2024
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor
Georges Gebrael, Yeonjung Jo, Vinay Mathew Thomas, et al.
European Urology Focus
|
April 5, 2024
Impact of Synchronous versus Metachronous Metastasis on Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with First-line Immune Checkpoint Inhibitor-based Combinations
Georges Gebrael, Luis Meza, Xiaochen Li, et al.
JAMA Network Open
|
April 7, 2026
Trends and Disparities in the Use of Next-Generation Sequencing in Patients With Cancer in the United States
Chadi Hage Chehade, Zeynep Irem Ozay, Yeonjung Jo, et al.
Page
of 8